- Research works
- 30 ▲ 39% vs 2013–17
- Citations
- 640 21.1 per fractional work
- Top-10% rate
- 2.5% record average 16.5%
- Open access
- 14% world 28%
Not ranked overall: Rare Breeds Survival Trust is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Which keywords describe research at Rare Breeds Survival Trust?
By fractional works in all years, weighted toward what it does more of than the world: Epidemiology, Quality of Life, Clinical Trials, Adverse Drug Reactions, Gender Differences, Immunotherapy, Autism Spectrum Disorders and Career Choice.
- Off-Label Drug Use
- Health Biotechnology
- Career Choice
- Public Health
- Gender Differences
- Clinical Trials
- Quality of Life
- Epidemiology
- Inflammation
- Adverse Drug Reactions
- Immunotherapy
- Autism Spectrum Disorders
- Global Collaboration
- Motivation
- Pediatric Pharmacokinetics
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 15 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 15 words, with their numbers
- Epidemiology3▲ 2.8×14 topics
- Quality of Life2▲ 4.9×5 topics
- Inflammation2▲ 2.3×6 topics
- Clinical Trials2▲ 8.0×4 topics
- Adverse Drug Reactions1▲ 67×2 topics
- Gender Differences1▲ 14×2 topics
- Immunotherapy1▲ 5.9×6 topics
- Public Health1▲ 2.8×4 topics
- Autism Spectrum Disorders1▲ 39×2 topics
- Career Choice1▲ 108×1 topic
- Global Collaboration1▲ 81×1 topic
- Health Biotechnology1▲ 174×1 topic
- Motivation1▲ 11×1 topic
- Off-Label Drug Use1▲ 89×1 topic
- Pediatric Pharmacokinetics1▲ 89×1 topic
Which research topics does Rare Breeds Survival Trust publish most on?
By volume in 2022–2025: Nanoplatforms for cancer theranostics, Cancer Research and Treatments, Immunotherapy and Immune Responses and Multiple Myeloma Research and Treatments.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Nanoplatforms for cancer theranostics Biomedical Engineering 0 works
- 2 Cancer Research and Treatments Biotechnology 0 works
- 3 Immunotherapy and Immune Responses Immunology 0 works
- 4 Multiple Myeloma Research and Treatments Hematology 0 works
- 5 Cancer Immunotherapy and Biomarkers Oncology 0 works
- 6 Cancer and biochemical research Molecular Biology 0 works
- 7 Malaria Research and Control Public Health, Environmental and Occupational Health 0 works
- 8 Hepatocellular Carcinoma Treatment and Prognosis Hepatology 0 works
- 9 Cholangiocarcinoma and Gallbladder Cancer Studies Surgery 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Rare Breeds Survival Trust's research output changed?
Output in 2018–2022 was 39% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Kenilworth
- AGCO (United Kingdom)
- National Farmers Union
- Agriculture and Horticulture Development Board
- Functional Technologies (United Kingdom)
- British Grassland Society
- Aeristech (United Kingdom)
- British Texel Sheep Society
- Royal Agricultural Society of England
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.